Detalhe da pesquisa
1.
Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancer.
Cancer Sci
; 110(3): 1117-1126, 2019 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-30697874
2.
NADPH oxidase 4 expression in the normal endometrium and in endometrial cancer.
Tumour Biol
; 41(2): 1010428319830002, 2019 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-30813866
3.
BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer.
Br J Cancer
; 119(6): 683-692, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30111871
4.
Postvoid residual bladder volume after uncomplicated vaginal delivery.
Int J Gynaecol Obstet
; 161(3): 820-826, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36637220
5.
The miR-34 family and its clinical significance in ovarian cancer.
J Cancer
; 11(6): 1446-1456, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32047551